Amicus Therapeutics, Inc. announced on May 8, 2024 that its management team will be participating in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV. The session is set for Wednesday, May 15, 2024 at 1:40 p.m. P.T. Interested parties can access a live audio webcast of the presentation through the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
Amicus Therapeutics is a global biotechnology company headquartered in Princeton, N.J., and listed on Nasdaq under the symbol FOLD. Its mission is to discover, develop and deliver high-quality medicines to individuals with rare diseases with a strong emphasis on meeting patient needs. To learn more about Amicus Therapeutics or to follow them on social media, visit their website at www.amicusrx.com and their X and LinkedIn pages respectively.
For investor inquiries, please contact Andrew Faughnan, Vice President of Investor Relations at afaughnan@amicusrx.com or (609) 662-3809. For media inquiries, reach out to Diana Moore, Head of Global Corporate Affairs and Communications at dmoore@amicusrx.com or (609) 662-5079